Pristyn Care was last valued at $1.4B (post-money). It comes from the $5.5M Series E of Jul 2025. The company is private, so there is no listed share price.
3 valuations. The latest, $1.4B post-money, was set by the Series E in Jul 2025.
A private valuation is the price agreed in one transaction. The Pristyn Care valuation of $1.4B is a post-money figure from the Series E dated 22 Jul 2025 — the whole company measured after the $5.5M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $1.4B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2018 with roughly 1,200 people has no daily price and no order book between rounds.
No. Pristyn Care is a private company; its shares do not trade on a public exchange.
The last valuation is $1.4B (post-money, Jul 2025).
Lead investors for each round are in the funding timeline.
The closest healthcare / health-tech (surgical care delivery) peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
